GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Cosmo Bio Co Ltd (TSE:3386) » Definitions » Institutional Ownership

Cosmo Bio Co (TSE:3386) Institutional Ownership : 0.00% (As of Apr. 24, 2025)


View and export this data going back to 2005. Start your Free Trial

What is Cosmo Bio Co Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Cosmo Bio Co's institutional ownership is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Cosmo Bio Co's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Cosmo Bio Co's Float Percentage Of Total Shares Outstanding is 0.00%.


Cosmo Bio Co Institutional Ownership Historical Data

The historical data trend for Cosmo Bio Co's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cosmo Bio Co Institutional Ownership Chart

Cosmo Bio Co Historical Data

The historical data trend for Cosmo Bio Co can be seen below:

2021-11-30 2021-12-31 2022-01-31 2022-02-28 2022-03-31 2022-04-30 2022-05-31 2022-06-30 2022-07-31 2022-08-31
Institutional Ownership 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02

Cosmo Bio Co Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Cosmo Bio Co Business Description

Traded in Other Exchanges
N/A
Address
2-20, Toyo-Ekimae Building, Toyo 2-Chome, Koto-ku, Tokyo, JPN, 135-0016
Cosmo Bio Co Ltd is a diagnostic and research company based in Japan. The business of the company includes purchase of reagents, instruments, clinical test drugs for research on life science and domestic sales.

Cosmo Bio Co Headlines

No Headlines